Respiratory

Latest News

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond repeated surgeries to manage the rare condition.

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

Obstructive sleep apnea syndrome. | Image Credit: Chinnapong - stock.adobe.com
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies

August 13th 2025

Acute respiratory failure. | Image Credit: Selvi - stock.adobe.com
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment

August 9th 2025

Chronic respiratory disease. | Image Credit: Tipapat - stock.adobe.com
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries

August 4th 2025

Continuing Medical Education
View All
August 23rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 23rd 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 23rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 23rd 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
August 23rd 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
August 23rd 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
August 23rd 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

image of e-cigarette device
January 4th 2023

e-Cigarette Use Higher Among US-Born Hispanic and Latino Young Males With Higher Education

Pearl Steinzor
A Hispanic community health study is the first of its kind to evaluate the prevalence and determinants of e-cigarette use among Hispanic and Latino populations living in the United States.
image with words "The Top 5 Respiratory Content for 2022"
December 24th 2022

Top 5 Most-Read Respiratory Content of 2022

Pearl Steinzor
This year’s most read articles on respiratory cover topics on long-term health effects of COVID-19, adolescent vaping, and more.
AJAC
December 15th 2022

How Ochsner, Xavier Are Working Together to Make Louisiana a Healthy State

Mary Caffrey Hayden E. Klein
Leaders from Ochsner, Xavier, and their partners gathered on September 13, 2022, in New Orleans to offer an overview of the Healthy State initiative during a session of the Institute for Value-Based Medicine®.
AJAC
December 14th 2022

Translating Tobacco Cessation Policy Into Practice

Neal D. Kohatsu, MD, MPH
Further understanding of effective incentives and disincentives is needed to ensure that evidence-based policy and guidelines regarding tobacco cessation are effectively translated into practice at the patient level.
AJAC
December 14th 2022

Responsibility for Treating Tobacco Dependence in Health Clinics Serving Medicaid Enrollees

Aaron Tam, BS Kimberly C. Brouwer, PhD Jie Liu, MD, MPH David Strong, PhD Sara W. Yoeun, MPH Paloma Mohn Sara B. McMenamin, PhD, MPH
This article describes the implementation of Medicaid smoking cessation guidance in a large, urban federally qualified health center to examine how state-level provisions translated into clinic-level policies.
picture of woman coughing
December 13th 2022

Study Examines Success Factors in Finishing Cough Suppression Therapy

Allison Inserro
Cough suppression therapy is a type of behavioral intervention, but like other behavioral interventions, it requires significant work on the part of the patient, meaning motivation, therapy attendance, and compliance with therapy techniques.
Julia Balmaceda
December 13th 2022

Study Examines Differences in Pulse Oximetry in Hospitalized Black, White Patients

Julia Balmaceda, a medical student at the University of Kansas, discusses the findings of a research project looking at whether racial bias in pulse oximetry was present in patients with acute hypoxemic respiratory failure.
image of newspapers on a table next to cup of coffee
December 12th 2022

What We’re Reading: Amgen to Buy Horizon for $27.8B; Indoor Masks Back Due to “Tripledemic”; Juul to Settle Vaping Cases for $1.7B

Amgen will buy Horizon Therapeutics for $27.8 billion as the largest health care merger of 2022; high levels of 3 respiratory illness incite reassessment of domestic indoor mask guidelines; Juul Labs is reported to pay $1.7 billion over 500 settlements that claim that e-cigarette addiction level is higher than advertised.
ICYMI: Top Highlights From the CHEST 2022 Meeting
December 7th 2022

ICYMI: Top Highlights From the CHEST 2022 Meeting

AJMC Staff
image of lungs highlighted inside a rendering of a body
December 6th 2022

Marijuana Smokers Have Higher Rates of Emphysema and Respiratory Disease, Study Finds

Pearl Steinzor
Increasing rates of marijuana consumption highlights a need for research on the effects of smoking marijuana on the lungs.
image of newspapers
December 2nd 2022

What We're Reading: Stress Aged Teenage Brains; WA Flu Deaths; Physicians File Brief in ACA Case

AJMC Staff
Teenage brains prematurely aged by 3 years during pandemic lockdowns; Washington state health officials report high flu activity and 7 deaths; medical groups ask a Texas judge to refrain from issuing a nationwide injunction against the preventive health screenings covered by the Affordable Care Act (ACA).
What We’re Reading: Children Missing Measles Shots; COVID-19 Booster Campaign Starts; Surgery Risks for Older Adults
November 28th 2022

What We’re Reading: Children Missing Measles Shots; COVID-19 Booster Campaign Starts; Surgery Risks for Older Adults

AJMC Staff
Nearly 40 million children missed their measles vaccine dose; health experts in the Biden administration are cautiously optimistic about a new campaign for COVID-19 boosters; about 1 in 7 older adults die within a year of having major surgery, according to a new study.
picture of globe
November 12th 2022

Health Societies Want Governments to Prioritize Fight Against Pneumonia

AJMC Staff
World Pneumonia Day is Saturday, November 12, and health organizations issued a call to action to do a better job of diagnosing, treating, and preventing the disease.
Man smoking
November 11th 2022

Study Finds Persistent Use of e-Cigarettes Among Middle, High School Students

Allison Inserro
The report, from the CDC, said that more than 3 million youth, or almost 1 in 9, reported using tobacco this year, and that disparities persist among US middle and high school students, with the highest rates among those who struggle in school or who have severe severe psychological distress.
What We're Reading
November 2nd 2022

What We’re Reading: Solving Racial Disparities in Pulse Oximeters; Tracheostomy Tube Shortage; Adult Deaths From Excessive Drinking

AJMC Staff
FDA advisers met to discuss alternatives to the infrared light used in pulse oximeters, which can be absorbed by melanin; FDA warns of a national shortage of tracheostomy tubes, especially for pediatric patients; 1 in 5 deaths among adults aged between 20 and 49 years is due to excessive drinking.
Woman with chronic cough
October 25th 2022

Phase 3 Study of Gefapixant in Japan Shows Good Safety, Tolerability Profile

AJMC Staff
The study sought to examine the safety and tolerability of gefapixant in Japanese patients with refractory or unexplained chronic cough.
Julia Balmaceda
October 21st 2022

2020's Tragedies Propel Student to Examine Race-Based Medical Bias

A medical student at the University of Kansas discusses a research project she started in her first year of school—2020—looking at whether a racial bias in pulse oximetry was present in patients with acute hypoxemic respiratory failure.
What We're Reading
October 10th 2022

What We’re Reading: Adderall Shortage Continues; Pertussis Vaccine Expanded for Infants; Breast Cancer Death Disparities

AJMC Staff
Teva, the largest US supplier of Adderall, expects shortages to continue for the next 2-3 months; FDA expands use of Boostrix for immunization during the third trimester of pregnancy to prevent pertussis in infants; over the last 3 decades, Black women had a 40% higher breast cancer death rate compared with White women.
Site Logo
October 10th 2022

Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation Unit

Celine Chang Chyi Ng, BPharm Stefan Kowalski, BPharm, MAppSc Wei Ling Mu, MNursing (APN) Pei Ting Tan, MSc Elaine Yin Leng Leong, MHealthAdmin Pak Liang Goh, MBBS Ru Peng Mong, MBBS Hoon Chin Lim, MBBS, MRCS (EM)
This study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.
Picture of teenagers
October 7th 2022

More Than 2.5 Million US Youth Reported Using e-Cigarettes in 2022

Pearl Steinzor
e-Cigarettes boasting fruity flavors and conveniently disposable devices are continuing to threaten US youth, agencies said.
Contributor: How to Fight the Cold and the Flu This Season
October 6th 2022

Contributor: How to Fight the Cold and the Flu This Season

Karla Huntsman, MSN, RN
With cold and flu season approaching, tips for avoiding the worst of the respiratory viruses are important for facing the coming months, when health experts expect an uptick in flu cases compared with the past 2 years.
Gunnar Esiason, patient advocate, Florence Healthcare
September 30th 2022

Contributor: It’s Time to Talk About Paying Clinical Trial Participants More

Gunnar Esiason
There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.
Child using nebulizer
September 28th 2022

CDC to Physicians: Watch for Severe Respiratory, Polio-Like Illness in Children

Allison Inserro
The CDC this week noted what providers and parents have been seeing across the country: rising cases of a non-polio enterovirus causing severe respiratory illness and acute flaccid myelitis (AFM).
What We're Reading
September 7th 2022

What We’re Reading: Expanding Monkeypox Vaccine Access; Annual COVID-19 Boosters; Juul to Pay in Teen Marketing Settlement

AJMC Staff
Under a new contract with AmerisourceBergen Corp, HHS will expand access to monkeypox vaccines and treatments; as President Jow Biden encouraged Americans to receive their COVID-19 boosters this fall, the White House signaled toward annual COVID-19 boosters; Juul has reached a settlement with 37 states and Puerto Rico regarding the company’s marketing to teens.
elderly patient getting a shot
September 1st 2022

Older Adults Benefit From High-Dose Influenza Vaccine

Laura Joszt, MA
A high-dose influenza vaccine reduces the risk of death and incidence of hospitalization for influenza and pneumonia among older adults.
graphic of antibiotic
August 28th 2022

Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy

Rose McNulty
The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate community-acquired pneumonia.
Image of vaccine solution
August 26th 2022

Pfizer Touts 85% Efficacy of RSV Vaccine for Adults, Will Seek FDA Approval

Allison Inserro
In the phase 3 trial, Pfizer’s vaccine was 85.7% effective against respiratory syncytial virus (RSV) defined by 3 or more symptoms among older adults.
N95 Mask
August 18th 2022

COVID-19 Is at Peak Infectiousness for 5 Days After Symptom Onset

Julia Bonavitacola
A recent cohort study found that two-thirds of patients could transmit SARS-CoV-2 at 5 days since their symptoms began; the median infectiousness duration in the sample was 5 days.
Woman coughing
August 11th 2022

Frequent Productive Cough Associated With Worse Outcomes in Asthma, COPD

Alisha Lekh
Frequent productive cough was experienced by patients with asthma and/or chronic obstructive pulmonary disease (COPD), with symptom prevalence increasing with higher disease severity, according to the results of a recent study.
COVID-19 molecule
August 9th 2022

ILD Associated With Higher Risk of COVID-19 Severity, Mortality

Alisha Lekh
Interstitial lung disease (ILD) was shown to correlate with an increased risk of both COVID-19 severity and mortality, according to a recent meta-analysis.
<123456789
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo